论文部分内容阅读
目的观察阿托伐他汀联合替罗非班治疗急性心肌梗死的临床效果。方法选取2009年7月—2013年7月我院收治的急性心肌梗死患者94例,根据就诊时间将其分为观察组和对照组,各47例。对照组采用常规疗法进行治疗,观察组在常规治疗的基础上采用阿托伐他汀联合替罗非班治疗,持续用药36 h,比较两组患者治疗效果。结果观察组总有效率为83.0%(39/47),高于对照组的74.5%(35/47)(P<0.05);观察组治疗期间1例患者出现胃肠不适、头痛、肌痛等不良反应。结论阿托伐他汀联合替罗非班治疗急性心肌梗死,疗效显著,且安全。
Objective To observe the clinical effect of atorvastatin combined with tirofiban in the treatment of acute myocardial infarction. Methods From July 2009 to July 2013, 94 patients with acute myocardial infarction admitted to our hospital were divided into observation group and control group according to the time of treatment, 47 cases in each group. The control group was treated by conventional therapy. The observation group was treated with atorvastatin combined with tirofiban on the basis of routine treatment for 36 hours. The therapeutic effect was compared between the two groups. Results The total effective rate in the observation group was 83.0% (39/47), which was higher than 74.5% (35/47) in the control group (P <0.05). One patient in the observation group had gastrointestinal discomfort, headache and myalgia Adverse reactions. Conclusions Atorvastatin combined with tirofiban in the treatment of acute myocardial infarction is effective and safe.